Attached files
file | filename |
---|---|
10-Q - ORAMED PHARMACEUTICALS INC. | v180690_10q.htm |
EX-31.2 - ORAMED PHARMACEUTICALS INC. | v180690_ex31-2.htm |
EX-32.2 - ORAMED PHARMACEUTICALS INC. | v180690_ex32-2.htm |
EX-31.1 - ORAMED PHARMACEUTICALS INC. | v180690_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Oramed Pharmaceuticals Inc. (the
“Company”) on Form 10-Q for the period ended February 28, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Nadav
Kidron, President, Chief Executive Officer and Director of the Company, certify,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities and Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.
|
Dated: April
12, 2010
|
By:
|
/s/ NADAV
KIDRON
|
||
Name: Nadav
Kidron
|
||||
Title: President,
Chief Executive Officer
|
||||
and
Director
|